In this study, we show that LAG-3 is a feasible target for generating a predictive imaging biomarker, with [89Zr]Zr-BI 754111 demonstrating a favorable tumor-to-background uptake, target specificity, and correlation with the immune status of the tumor biopsies at baseline. This evidence concerns the gene LAG3 and neoplasm.